DUOFILM

This brand name is authorized in Australia, Austria, Brazil, Estonia, France, Hong Kong SAR China, Ireland, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Tunisia, UK.

Active ingredients

The drug DUOFILM contains a combination of these active pharmaceutical ingredients (APIs):

1	Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID
	Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium.
	Read more about Salicylic acid
2	Lactic acid UNII 33X04XA5AT - LACTIC ACID, UNSPECIFIED FORM
	Read more about Lactic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D11AF	Wart and anti-corn preparations	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations
Discover more medicines within D11AF

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11959K
BR	Câmara de Regulação do Mercado de Medicamentos	522601101173312, 522601102161318
EE	Ravimiamet	1040780, 1822621
FR	Base de données publique des médicaments	66684969
GB	Medicines & Healthcare Products Regulatory Agency	297314
HK	Department of Health Drug Office	12847
MT	Medicines Authority	AA908/08802
NL	Z-Index G-Standaard	14309785
NL	Z-Index G-Standaard, PRK	72451
NZ	Medicines and Medical Devices Safety Authority	4247
PL	Rejestru Produktów Leczniczych	100079330
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67098001
SG	Health Sciences Authority	04047P
TN	Direction de la Pharmacie et du Médicament	17833031
ZA	Health Products Regulatory Authority	S/13.8/82